These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 23380305

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Heterogeneity of histaminergic neurons in the tuberomammillary nucleus of the rat.
    Giannoni P, Passani MB, Nosi D, Chazot PL, Shenton FC, Medhurst AD, Munari L, Blandina P.
    Eur J Neurosci; 2009 Jun; 29(12):2363-74. PubMed ID: 19490084
    [Abstract] [Full Text] [Related]

  • 3. Pharmacological properties of ABT-239 [4-(2-{2-[(2R)-2-Methylpyrrolidinyl]ethyl}-benzofuran-5-yl)benzonitrile]: II. Neurophysiological characterization and broad preclinical efficacy in cognition and schizophrenia of a potent and selective histamine H3 receptor antagonist.
    Fox GB, Esbenshade TA, Pan JB, Radek RJ, Krueger KM, Yao BB, Browman KE, Buckley MJ, Ballard ME, Komater VA, Miner H, Zhang M, Faghih R, Rueter LE, Bitner RS, Drescher KU, Wetter J, Marsh K, Lemaire M, Porsolt RD, Bennani YL, Sullivan JP, Cowart MD, Decker MW, Hancock AA.
    J Pharmacol Exp Ther; 2005 Apr; 313(1):176-90. PubMed ID: 15608077
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Regional differential effects of the novel histamine H3 receptor antagonist 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methyl-3-pyridinecarboxamide hydrochloride (GSK189254) on histamine release in the central nervous system of freely moving rats.
    Giannoni P, Medhurst AD, Passani MB, Giovannini MG, Ballini C, Corte LD, Blandina P.
    J Pharmacol Exp Ther; 2010 Jan; 332(1):164-72. PubMed ID: 19815811
    [Abstract] [Full Text] [Related]

  • 6. Donepezil, an acetylcholine esterase inhibitor, and ABT-239, a histamine H3 receptor antagonist/inverse agonist, require the integrity of brain histamine system to exert biochemical and procognitive effects in the mouse.
    Provensi G, Costa A, Passani MB, Blandina P.
    Neuropharmacology; 2016 Oct; 109():139-147. PubMed ID: 27291828
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Cortical acetylcholine release elicited by stimulation of histamine H1 receptors in the nucleus basalis magnocellularis: a dual-probe microdialysis study in the freely moving rat.
    Cecchi M, Passani MB, Bacciottini L, Mannaioni PF, Blandina P.
    Eur J Neurosci; 2001 Jan; 13(1):68-78. PubMed ID: 11135005
    [Abstract] [Full Text] [Related]

  • 9. A robust and high-capacity [(35)S]GTPgammaS binding assay for determining antagonist and inverse agonist pharmacological parameters of histamine H(3) receptor ligands.
    Miller TR, Baranowski JL, Estvander BR, Witte DG, Carr TL, Manelli AM, Krueger KM, Cowart MD, Brioni JD, Esbenshade TA.
    Assay Drug Dev Technol; 2008 Jun; 6(3):339-49. PubMed ID: 18593375
    [Abstract] [Full Text] [Related]

  • 10. Histamine H3 receptor antagonism by ABT-239 attenuates kainic acid induced excitotoxicity in mice.
    Bhowmik M, Saini N, Vohora D.
    Brain Res; 2014 Sep 18; 1581():129-40. PubMed ID: 24952295
    [Abstract] [Full Text] [Related]

  • 11. Differential effect of cannabinoid agonists and endocannabinoids on histamine release from distinct regions of the rat brain.
    Cenni G, Blandina P, Mackie K, Nosi D, Formigli L, Giannoni P, Ballini C, Della Corte L, Mannaioni PF, Passani MB.
    Eur J Neurosci; 2006 Sep 18; 24(6):1633-44. PubMed ID: 17004927
    [Abstract] [Full Text] [Related]

  • 12. The role of cortical and hypothalamic histamine-3 receptors in the modulation of central histamine neurotransmission: an in vivo electrophysiology and microdialysis study.
    Flik G, Dremencov E, Cremers TI, Folgering JH, Westerink BH.
    Eur J Neurosci; 2011 Dec 18; 34(11):1747-55. PubMed ID: 22050612
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological properties and procognitive effects of ABT-288, a potent and selective histamine H3 receptor antagonist.
    Esbenshade TA, Browman KE, Miller TR, Krueger KM, Komater-Roderwald V, Zhang M, Fox GB, Rueter L, Robb HM, Radek RJ, Drescher KU, Fey TA, Bitner RS, Marsh K, Polakowski JS, Zhao C, Cowart MD, Hancock AA, Sullivan JP, Brioni JD.
    J Pharmacol Exp Ther; 2012 Oct 18; 343(1):233-45. PubMed ID: 22815533
    [Abstract] [Full Text] [Related]

  • 14. Histamine neurons in the tuberomamillary nucleus: a whole center or distinct subpopulations?
    Blandina P, Munari L, Provensi G, Passani MB.
    Front Syst Neurosci; 2012 Oct 18; 6():33. PubMed ID: 22586376
    [Abstract] [Full Text] [Related]

  • 15. In-vivo histamine H3 receptor antagonism activates cellular signaling suggestive of symptomatic and disease modifying efficacy in Alzheimer's disease.
    Bitner RS, Markosyan S, Nikkel AL, Brioni JD.
    Neuropharmacology; 2011 Oct 18; 60(2-3):460-6. PubMed ID: 21044639
    [Abstract] [Full Text] [Related]

  • 16. The 5-hydroxytryptamine4 receptor agonists prucalopride and PRX-03140 increase acetylcholine and histamine levels in the rat prefrontal cortex and the power of stimulated hippocampal θ oscillations.
    Johnson DE, Drummond E, Grimwood S, Sawant-Basak A, Miller E, Tseng E, McDowell LL, Vanase-Frawley MA, Fisher KE, Rubitski DM, Stutzman-Engwall KJ, Nelson RT, Horner WE, Gorczyca RR, Hajos M, Siok CJ.
    J Pharmacol Exp Ther; 2012 Jun 18; 341(3):681-91. PubMed ID: 22408061
    [Abstract] [Full Text] [Related]

  • 17. Identification of a histaminergic circuit in the caudal hypothalamus: an evidence for functional heterogeneity of histaminergic neurons.
    Umehara H, Mizuguchi H, Fukui H.
    Neurochem Int; 2012 Nov 18; 61(6):942-7. PubMed ID: 22677810
    [Abstract] [Full Text] [Related]

  • 18. Glutamatergic regulation of brain histamine neurons: In vivo microdialysis and electrophysiology studies in the rat.
    Fell MJ, Flik G, Dijkman U, Folgering JH, Perry KW, Johnson BJ, Westerink BH, Svensson KA.
    Neuropharmacology; 2015 Dec 18; 99():1-8. PubMed ID: 26100446
    [Abstract] [Full Text] [Related]

  • 19. Correlation between ex vivo receptor occupancy and wake-promoting activity of selective H3 receptor antagonists.
    Le S, Gruner JA, Mathiasen JR, Marino MJ, Schaffhauser H.
    J Pharmacol Exp Ther; 2008 Jun 18; 325(3):902-9. PubMed ID: 18305012
    [Abstract] [Full Text] [Related]

  • 20. In vivo pharmacological profile of S 38093, a novel histamine H3 receptor inverse agonist.
    Panayi F, Sors A, Bert L, Martin B, Rollin-Jego G, Billiras R, Carrié I, Albinet K, Danober L, Rogez N, Thomas JY, Pira L, Bertaina-Anglade V, Lestage P.
    Eur J Pharmacol; 2017 May 15; 803():1-10. PubMed ID: 28315340
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.